Breckenridge Announces Final Approval of its ANDA for Pomalidomide Capsules (generic for Pomalyst®)
BERLIN, Conn., Nov. 13, 2020 /PRNewswire/ -- Breckenridge Pharmaceutical, Inc. announced today that the U.S. Food and Drug Administration has approved...











